DK0411629T3 - Fremgangsmåde til mikronisering af et tungtopløseligt lægemiddel - Google Patents

Fremgangsmåde til mikronisering af et tungtopløseligt lægemiddel

Info

Publication number
DK0411629T3
DK0411629T3 DK90114858.5T DK90114858T DK0411629T3 DK 0411629 T3 DK0411629 T3 DK 0411629T3 DK 90114858 T DK90114858 T DK 90114858T DK 0411629 T3 DK0411629 T3 DK 0411629T3
Authority
DK
Denmark
Prior art keywords
micronizing
soluble drug
drug
heavily soluble
heavily
Prior art date
Application number
DK90114858.5T
Other languages
Danish (da)
English (en)
Inventor
Masayoshi Samejima
Kazuo Noda
Masao Kobayashi
Takashi Osawa
Original Assignee
Tanabe Seiyaku Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanabe Seiyaku Co filed Critical Tanabe Seiyaku Co
Application granted granted Critical
Publication of DK0411629T3 publication Critical patent/DK0411629T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
DK90114858.5T 1989-08-04 1990-08-02 Fremgangsmåde til mikronisering af et tungtopløseligt lægemiddel DK0411629T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1204132A JP2642486B2 (ja) 1989-08-04 1989-08-04 難溶性薬物の超微粒子化法

Publications (1)

Publication Number Publication Date
DK0411629T3 true DK0411629T3 (da) 1993-12-13

Family

ID=16485367

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90114858.5T DK0411629T3 (da) 1989-08-04 1990-08-02 Fremgangsmåde til mikronisering af et tungtopløseligt lægemiddel

Country Status (9)

Country Link
US (1) US5202129A (ja)
EP (1) EP0411629B1 (ja)
JP (1) JP2642486B2 (ja)
KR (1) KR0126465B1 (ja)
AT (1) ATE96658T1 (ja)
CA (1) CA2022465C (ja)
DE (1) DE69004372T2 (ja)
DK (1) DK0411629T3 (ja)
ES (1) ES2062221T3 (ja)

Families Citing this family (112)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) * 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
FR2684298B1 (fr) * 1991-12-03 1994-03-11 Rhone Poulenc Rorer Sa Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
US5302400A (en) * 1992-06-22 1994-04-12 Digestive Care Inc. Preparation of gastric acid-resistant microspheres containing digestive enzymes and buffered-bile acids
US7336788B1 (en) * 1992-12-09 2008-02-26 Discovery Communicatoins Inc. Electronic book secure communication with home subsystem
ATE178794T1 (de) * 1993-01-19 1999-04-15 Warner Lambert Co Stabilisierte, oral anzuwendende zusammensetzung enthaltend die verbindung ci-981 und verfahren
US20070117862A1 (en) * 1993-02-22 2007-05-24 Desai Neil P Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
TW402506B (en) * 1993-06-24 2000-08-21 Astra Ab Therapeutic preparation for inhalation
IS1796B (is) * 1993-06-24 2001-12-31 Ab Astra Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
US6794357B1 (en) 1993-06-24 2004-09-21 Astrazeneca Ab Compositions for inhalation
US5747445A (en) * 1993-06-24 1998-05-05 Astra Aktiebolag Therapeutic preparation for inhalation
US20010003739A1 (en) * 1993-06-24 2001-06-14 Astrazeneca Ab Systemic administration of a therapeutic preparation
US5830853A (en) * 1994-06-23 1998-11-03 Astra Aktiebolag Systemic administration of a therapeutic preparation
US6632456B1 (en) 1993-06-24 2003-10-14 Astrazeneca Ab Compositions for inhalation
US7865567B1 (en) 1993-12-02 2011-01-04 Discovery Patent Holdings, Llc Virtual on-demand electronic book
US6165976A (en) 1994-06-23 2000-12-26 Astra Aktiebolag Therapeutic preparation for inhalation
WO1996003976A1 (en) * 1994-08-01 1996-02-15 Kv Pharmaceutical Corporation Tastemasked liquid pharmaceutical delivery system
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
SE9404468D0 (sv) * 1994-12-22 1994-12-22 Astra Ab Powder formulations
CN1170527C (zh) 1994-12-22 2004-10-13 阿斯特拉公司 含有甲状旁腺激素(pth)的吸入用治疗剂
US6524557B1 (en) 1994-12-22 2003-02-25 Astrazeneca Ab Aerosol formulations of peptides and proteins
BR9510510A (pt) 1994-12-22 1998-07-07 Astra Ab Formulação em aerossol farmacêutica uso da mesma e processos para fabricação da mesma para tratamento de um paciente carente de terapia
US5503723A (en) * 1995-02-08 1996-04-02 Eastman Kodak Company Isolation of ultra small particles
US6458811B1 (en) * 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
US5750104A (en) * 1996-05-29 1998-05-12 Digestive Care Inc. High buffer-containing enteric coating digestive enzyme bile acid compositions and method of treating digestive disorders therewith
NZ502500A (en) * 1997-06-27 2002-03-28 Vivorx Pharmaceuticals Inc Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
ZA991922B (en) 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
US6197347B1 (en) 1998-06-29 2001-03-06 Andrx Pharmaceuticals, Inc. Oral dosage for the controlled release of analgesic
US7521068B2 (en) 1998-11-12 2009-04-21 Elan Pharma International Ltd. Dry powder aerosols of nanoparticulate drugs
US6432448B1 (en) * 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
EG23951A (en) * 1999-03-25 2008-01-29 Otsuka Pharma Co Ltd Cilostazol preparation
US6787531B1 (en) * 1999-08-31 2004-09-07 Schering Ag Pharmaceutical composition for use as a contraceptive
US6500462B1 (en) * 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
CA2395129C (en) 1999-12-20 2008-12-16 Nicholas J. Kerkhof Process for producing nanometer particles by fluid bed spray-drying
US8771740B2 (en) 1999-12-20 2014-07-08 Nicholas J. Kerkhof Process for producing nanoparticles by spray drying
EP1318809A1 (en) * 2000-08-14 2003-06-18 Teva Pharmaceutical Industries Ltd. Micronized torsemide
US6699315B2 (en) 2000-11-28 2004-03-02 Fmc Corporation Edible PGA coating composition
US6932861B2 (en) * 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
US6544552B2 (en) 2001-01-11 2003-04-08 Particle And Coating Technologies, Inc. Method of producing porous tablets with improved dissolution properties
JP2004537506A (ja) 2001-03-01 2004-12-16 ホリス − イーデン ファーマスーティカルズ、 インコーポレイテッド 血液細胞欠乏症を治療するためのある種のステロイドの使用
JP2004530557A (ja) * 2001-06-29 2004-10-07 エウランド ファルマチェウティカルズ リミテッド 薬剤活性化方法およびそのための振動ミル
WO2007064311A1 (en) * 2001-07-10 2007-06-07 Teva Pharmaceutical Industries Ltd. Micronized mirtazapine
JP2004537401A (ja) 2001-08-08 2004-12-16 ブラウン ユニバーシティ リサーチ ファウンデーション 疎水性薬物の微粉砕方法
US8506617B1 (en) 2002-06-21 2013-08-13 Advanced Cardiovascular Systems, Inc. Micronized peptide coated stent
US7033602B1 (en) 2002-06-21 2006-04-25 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of coating implantable medical devices
US7070798B1 (en) 2002-06-21 2006-07-04 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical devices incorporating chemically-bound polymers and oligomers of L-arginine
US7217426B1 (en) 2002-06-21 2007-05-15 Advanced Cardiovascular Systems, Inc. Coatings containing polycationic peptides for cardiovascular therapy
US6994867B1 (en) 2002-06-21 2006-02-07 Advanced Cardiovascular Systems, Inc. Biocompatible carrier containing L-arginine
US7794743B2 (en) * 2002-06-21 2010-09-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7011842B1 (en) 2002-06-21 2006-03-14 Advanced Cardiovascular Systems, Inc. Polycationic peptide coatings and methods of making the same
US7056523B1 (en) 2002-06-21 2006-06-06 Advanced Cardiovascular Systems, Inc. Implantable medical devices incorporating chemically conjugated polymers and oligomers of L-arginine
US20040048931A1 (en) * 2002-07-12 2004-03-11 Craig Heacock Modafinil pharmaceutical compositions
US7094256B1 (en) 2002-12-16 2006-08-22 Advanced Cardiovascular Systems, Inc. Coatings for implantable medical device containing polycationic peptides
US20040121003A1 (en) * 2002-12-19 2004-06-24 Acusphere, Inc. Methods for making pharmaceutical formulations comprising deagglomerated microparticles
US20040146537A1 (en) * 2003-01-28 2004-07-29 Ramachandran Radhakrishnan Oily wax matrix suspension formulation comprising pharmacologically active agents
CA2511992A1 (en) * 2003-02-24 2004-09-10 Mallinckrodt Inc. Process for preparing benzhydrylthioacetamide
US20040253308A1 (en) * 2003-04-29 2004-12-16 Barr Laboratories, Inc. Surface-treated modafinil particles
BRPI0412523A (pt) * 2003-07-11 2006-09-19 Hoffmann La Roche forma de dosagem oral de mesilato de saquinavir
JP2006528182A (ja) * 2003-07-18 2006-12-14 サンタラス インコーポレイティッド 薬学的製剤および酸に起因する消化器疾患の治療法
WO2005051511A1 (ja) * 2003-11-28 2005-06-09 Mitsubishi Chemical Corporation 有機化合物微粒子の製造方法
AU2004314213A1 (en) * 2004-01-08 2005-08-04 Wyeth Directly compressible pharmaceutical composition for the oral admimistration of CCI-779
AU2005330504B2 (en) 2004-09-29 2010-10-28 Harbor Biosciences, Inc. Steroid analogs and characterization and treatment methods
ES2231043B2 (es) * 2004-10-29 2005-10-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
JP4754211B2 (ja) * 2004-12-28 2011-08-24 ライオン株式会社 粒状医薬組成物及びその製造方法
CN104083342A (zh) * 2004-12-31 2014-10-08 伊休蒂卡有限公司 纳米微粒组合物及其合成方法
CN101232905B (zh) * 2005-07-25 2013-01-09 大塚制药株式会社 一种用于测量嘧啶代谢能力的口服制剂
MX2008001532A (es) * 2005-08-02 2008-04-22 Drossapharm Ag Composicion farmaceutica que contiene indometacina y/o acemetacina.
US20070092576A1 (en) * 2005-10-20 2007-04-26 Adolor Corporation Compositions containing opioid antagonists
US20070148211A1 (en) * 2005-12-15 2007-06-28 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for oral administration
US20070178166A1 (en) * 2005-12-15 2007-08-02 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
KR20080096851A (ko) * 2006-03-06 2008-11-03 테바 파마슈티컬 인더스트리즈 리미티드 에제티미베 조성물
JP2007314529A (ja) * 2006-04-28 2007-12-06 Lion Corp 造粒粒子、錠剤、及び造粒粒子の製造方法
AU2012203877B2 (en) * 2006-06-30 2013-10-10 Iceutica Pty Ltd Methods For The Preparation Of Biologically Active Compounds In Nanoparticulate Form
TWI564033B (zh) * 2006-06-30 2017-01-01 艾修提卡股份有限公司 製造奈米微粒形式生物活性化合物之方法
AU2016203251B2 (en) * 2006-06-30 2017-11-16 Iceutica Pty Ltd Methods for the Preparation of Biologically Active Compounds in Nanoparticle Form
AU2013273795C1 (en) * 2006-06-30 2016-08-18 Iceutica Pty Ltd Method for the Preparation of Biologically Active Compounds in Nanoparticle Form
WO2008000042A1 (en) * 2006-06-30 2008-01-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
US20080181966A1 (en) * 2006-10-18 2008-07-31 Cephalon, Inc. Modafinil pharmaceutical compositions
FI2140867T4 (fi) * 2007-03-29 2023-09-14 Farmaseuttinen koostumus
TWI405590B (zh) * 2007-04-06 2013-08-21 Activus Pharma Co Ltd 微粉碎化有機化合物粒子之製法
CA2683712A1 (en) * 2007-04-20 2009-01-15 Sun Pharmaceutical Industries Limited Pharmaceutical compositions
JP2009091298A (ja) * 2007-10-10 2009-04-30 Asuka Corporation:Kk 皮膚改善化粧料
EP2293791B1 (en) * 2008-02-06 2011-11-23 Wockhardt Limited Pharmaceutical compositions of entacapone co-micronized with sugar alcohols
EP2252284B1 (en) * 2008-02-06 2011-05-25 Wockhardt Research Centre Pharmaceutical compositions of entacapone, levodopa and carbidopa with improved bioavailability
US20170105966A1 (en) * 2008-02-28 2017-04-20 Roger Imboden Pharmaceutical composition containing indometacin and/or acemetacin
EP2273994B1 (en) 2008-04-03 2015-12-02 NeurMedix, Inc. Solid state forms of a pharmaceutical
JP5149673B2 (ja) * 2008-04-03 2013-02-20 有限会社不動権現 こんにゃく粉製造方法
US20100016450A1 (en) * 2008-07-21 2010-01-21 Otonomy, Inc. Controlled release delivery devices for the treatment of otic disorders
DE102008037025C5 (de) * 2008-08-08 2016-07-07 Jesalis Pharma Gmbh Verfahren zur Herstellung kristalliner Wirkstoff-Mikropartikel bzw. einer Wirkstoffpartikel-Festkörperform
US20110165259A1 (en) 2008-09-19 2011-07-07 Activus Pharma Co., Ltd. Composite organic compound powder for medical use, method for producing same and suspension of same
EP2168573A1 (en) * 2008-09-30 2010-03-31 LEK Pharmaceuticals D.D. Formulations comprising ezetimibe
CN106420667A (zh) 2009-04-24 2017-02-22 伊休蒂卡有限公司 双氯芬酸的新剂型
MX360545B (es) * 2009-04-24 2018-10-26 Iceutica Pty Ltd Método para mejorar el perfil de disolución de un material biológicamente activo.
JP6141013B2 (ja) * 2009-04-24 2017-06-07 イシューティカ ピーティーワイ リミテッド 商業的規模での封入ナノ粒子の製造
SG175315A1 (en) 2009-04-24 2011-11-28 Iceutica Pty Ltd A novel formulation of indomethacin
SG10201401720RA (en) * 2009-04-24 2014-06-27 Iceutica Pty Ltd A novel formulation of naproxen
CN102740836A (zh) * 2009-04-24 2012-10-17 伊休蒂卡有限公司 用于制备商品化纳米颗粒和微粒粉末的方法
WO2010121324A1 (en) * 2009-04-24 2010-10-28 Iceutica Pty Ltd A novel formulation of metaxalone
EP2484383B1 (en) 2009-09-30 2021-04-28 Kabushiki Kaisha Sangi Method for improving the aqueous solubility of poorly-soluble substances
JP5390014B2 (ja) 2010-03-19 2014-01-15 第一三共株式会社 抗凝固剤の溶出改善方法
CA2793241C (en) 2010-03-22 2020-07-14 Bio-Synectics Inc. Method for preparing nano-particles
CN102408756B (zh) * 2011-08-05 2013-06-19 中国人民解放军第四军医大学 DiI 显微颗粒简易制作及其标记神经元的方法
ES2673182T3 (es) 2011-08-10 2018-06-20 Daiichi Sankyo Company, Limited Composición farmacéutica que contiene un derivado de diamina
KR101794032B1 (ko) 2011-09-21 2017-11-07 (주)바이오시네틱스 나노입자 제조방법
JP5909796B2 (ja) 2012-03-02 2016-04-27 株式会社サンギ 難溶性物質の水溶解性改善方法
CN104737016B (zh) 2012-08-20 2017-09-29 大塚制药株式会社 测定糖代谢能力的方法及用于该方法的组合物
ES2754246T3 (es) 2013-03-15 2020-04-16 Otsuka Pharma Co Ltd Composición para su uso en un método para medir la razón de combustión azúcar/ácido graso
US9526734B2 (en) 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
WO2017209216A1 (ja) * 2016-05-31 2017-12-07 協和発酵キリン株式会社 難溶性薬物の微粒子を含有する医薬組成物の製造方法
ES2813561T3 (es) 2017-09-07 2021-03-24 Tiefenbacher Alfred E Gmbh & Co Kg Composición farmacéutica en comprimido que comprende bilastina
EP3470062B1 (en) 2017-12-18 2020-10-28 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical tablet composition comprising bilastine polymorphic form 3 and magnesium aluminometasilicate
JP7421542B2 (ja) * 2019-03-06 2024-01-24 株式会社 伊藤園 植物含有組成物の製造方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE773113A (fr) * 1970-09-28 1972-01-17 Controlled Medications Composition pharmaceutique a liberation progressive de la substance active
FR2162245A1 (en) * 1971-12-06 1973-07-20 Sobio Lab Micronized l-dopa - with increased bioavailability
FR2257266B1 (ja) * 1974-01-10 1977-07-01 Pasteur Institut
DE2401037C2 (de) * 1974-01-10 1978-03-30 Eric G. 7000 Stuttgart Doubleday Rohrstück für Reinigungsmaschinen, insbesondere für Staub- oder Flüssigkeitssauggeräte
JPS5132718A (en) * 1974-09-13 1976-03-19 Yoshinobu Nakai Nanyoseiyakuhin no yoshutsusokudochosetsuho
JPS59101423A (ja) * 1982-12-02 1984-06-12 Takada Seiyaku Kk 新規なニフエジピン固形製剤
US4753800A (en) * 1985-10-04 1988-06-28 Warner-Lambert Company Medicament adsorbates and their preparation
JPH0215026A (ja) * 1988-07-01 1990-01-18 Takada Seiyaku Kk 新規なプロブコール固形製剤
HU200926B (en) * 1988-10-28 1990-09-28 Egyt Gyogyszervegyeszeti Gyar Pharmaceutical composition comprising piroxicam and lactose for use in making tablets or capsules

Also Published As

Publication number Publication date
EP0411629A3 (en) 1991-05-08
US5202129A (en) 1993-04-13
KR0126465B1 (ko) 1997-12-24
CA2022465C (en) 1998-04-21
CA2022465A1 (en) 1991-02-05
JP2642486B2 (ja) 1997-08-20
JPH0366613A (ja) 1991-03-22
DE69004372T2 (de) 1994-04-21
DE69004372D1 (de) 1993-12-09
ES2062221T3 (es) 1994-12-16
EP0411629A2 (en) 1991-02-06
KR910004183A (ko) 1991-03-28
ATE96658T1 (de) 1993-11-15
EP0411629B1 (en) 1993-11-03

Similar Documents

Publication Publication Date Title
DK0411629T3 (da) Fremgangsmåde til mikronisering af et tungtopløseligt lægemiddel
PT95312A (pt) Processo para a preparacao de novos tienilcarboxilatos de aminoalcoois e dos seus produtos de quaternizacao, e de composicoes farmaceuticas que os contem
PT84785B (pt) Processo para a preparacao de composicoes farmceuticas que contem omeprazole para administracao por via oral
HUT46710A (en) Process for producing peptode derivatives and pharmaceutical compositions containing them as active components
AU2581888A (en) Stabilized medicinal substances, a process for the preparation thereof, and stable medicinal formulations
HU903846D0 (en) Process for producing imidazolyl-alkenic acids and pharmaceutical preparatives containing these compounds as active substance
HUT47552A (en) Process for producing 10-dihydro-10-deoxo-11-aza-erythronolid a derivatives and pharmaceutical compositions containing them as active components
PT82610B (pt) Processo para a preparacao de tiazolidino-dionas hipoglicemicas
HUT51279A (en) Process for producing 2-phosphate-esters of ascorbinic acid and pharmaceutical compositions containing them as active components
FI100047B (fi) Menetelmä stabiilin tooppisen farmaseuttisen seoksen valmistamiseksi
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
EP0404283A3 (de) 11-Beta-aryl-4-estrene, Verfahren zu ihrer Herstellung sowie deren Verwendung als Arzneimittel
PT96304A (pt) Processo para a preparacao de novos derivados de cromano e de tiocromano e de composicoes farmaceuticas que os contem
HUT51620A (en) Process for producing multicyclic pyrimidine derivatives and pharmaceutical preparations containing these compounds as active substance
BR9304431A (pt) Medicamento processo para sua preparaçao e aplicaçao de uma mistura
WO1987004926A3 (en) Method of modifying the lipid structure of cell membranes and pharmaceutical compositions for use therein
PT91682A (pt) Processo para a preparacao de composicoes farmaceuticas contendo etoposido
AU1950388A (en) Pharmaceutical formulation ensuring the transdermal absorption of the active ingredient and process for preparing same
HUT50112A (en) Process for producing phenoxyalkyl-carboxylic acid derivatives and pharmaceutical compositions containing them as active component
PT86874A (pt) Process for the preparation of cromona by products and of pharmaceutical compounds containing them
HUT45537A (en) Process for producing delta-22 derivatives of ll-f 28249 compounds and pharmaceutical compositions containing them as active components, and insecticide compositions
FR2422640A1 (fr) Nouvelles morphinane-6-ones a substituant 8b-alkyle, leur procede de production et medicament les contenant
HU906459D0 (en) Process for producing new pyridone derivatives and pharmaceutical preparatives containing them as active substance
HUT48642A (en) Process for producing amino-acid derivatives and pharmaceutical compositions containing them as active components
HUT48232A (en) Process for producing new biphenyl derivatives and pharmaceutical compositions comprising such compounds as active ingredient